Where does Heron Neutron Medical Corp. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Heron Neutron Medical Corp. ranks #28,967 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Heron Neutron Medical Corp. hold?

Heron Neutron Medical Corp. holds 9 US utility patents granted between 2020 and 2025, spanning 9 technology areas.

What is Heron Neutron Medical Corp.'s Innovation Score?

Heron Neutron Medical Corp. has an Innovation Score of 36.3 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Heron Neutron Medical Corp. focus on?

Heron Neutron Medical Corp.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 7 patents, ranking #515 of 1,943 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Heron Neutron Medical Corp.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Heron Neutron Medical Corp..

What does claim depth mean for Heron Neutron Medical Corp.'s patents?

Heron Neutron Medical Corp.'s patents average 12.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Heron Neutron Medical Corp. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Heron Neutron Medical Corp.

USPTO PatentsView assignee record - 9 granted patents across 9 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Heron ranks #28,967 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 9 technology areas.

#28,967
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.3/100): 12.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R28967 · Foreign Corporation #28,967 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 9 grants
MID-PACK #28,967/49,997
PHOTO-FINISH Hemlock Semiconducto…
CPC-NARROW A61N · 9 areas
INNOV-THIN 36.3/100
CLAIMS-RICH 12.9 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Hemlock Semiconductor Operations LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Heron’s 36.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.0 pts (22%) Velocity 10.0 pts (28%) Breadth 10.6 pts (29%) Claim depth 7.7 pts (21%)

Qualcomm Incorporated · highest

85
Heron Neutron Medical · this assignee

36
3D Lighting… · lowest

7

What this shows Heron's Innovation Score is 36.3/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Heron?

Each dot is one of Heron’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Heron’s own 12.9 claims/patent is at or below the 13.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Heron vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Heron's grants concentrate

Heron Neutron Medical Corp. is a focused PatentsView assignee: 9 CPC subclasses with 77.8% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2020. By volume, Heron sits between Hemlock Semiconductor Operations LLC and Hickies, Inc..

Heron's three-year grant acceleration

Heron Neutron Medical Corp. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hemlock Semicondu…

9
Hengdian Group In…

9
Hero Health

9
Hero Scientific

9
Hexagon Geosystem…

9
Heys International

9
HG Partners

9
Hickies

9
Heron Neutron Med… ◀

9

What this shows Heron holds 9 patents at rank #28,932, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Heron

By rank, the assignees closest to #28,932 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Heron's primary technology class.

Heron's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Heron Neutron Medical Corp. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	11.1%
2021	1	11.1%
2022	2	22.2%
2023	1	11.1%
2025partial year	4	44.4%

Which technologies does Heron Neutron Medical Corp. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 7

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 7

G21K - Techniques FOR Handling Particles OR Ionising Radiation NOT Otherwise Provided FOR; Irradiation DEVICES; Gamma RAY OR X-ray Microscopes 2

G01T - Measurement OF Nuclear OR X-radiation 1

A61B - DIAGNOSIS; SURGERY; Identification 1

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 1

F28D - Heat-exchange Apparatus, NOT Provided FOR IN Another Subclass, IN Which THE Heat-exchange Media DO NOT Come Into Direct Contact 1

F28F - Details OF Heat-exchange AND Heat-transfer Apparatus, OF General Application 1

G21G - Conversion OF Chemical ELEMENTS; Radioactive Sources 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Heron Neutron Medical Corp.'s patent record in context - here's where to go next.

Heron Neutron Medical Corp.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 77.8% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #28,967 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Heron Neutron Medical Corp. against Hemlock Semiconductor Operations LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.